Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0519 Transporter Info | ||||
| Gene Name | CACNA1B | ||||
| Transporter Name | Voltage-gated calcium channel alpha Cav2.2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Econazole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3198 | ||||
| Docking Score | -8.052 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C18H15Cl3N2O | ||||
| Molecular Weight | 381.7 | ||||
| Canonical SMILES |
C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
|
||||
| InChI |
InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2
|
||||
| InChIKey | LEZWWPYKPKIXLL-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.3 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
| Xenobiotic Name | Lomerizine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3949 | ||||
| Docking Score | -7.775 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C27H30F2N2O3 | ||||
| Molecular Weight | 468.5 | ||||
| Canonical SMILES |
COC1=C(C(=C(C=C1)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC)OC
|
||||
| InChI |
InChI=1S/C27H30F2N2O3/c1-32-24-13-8-21(26(33-2)27(24)34-3)18-30-14-16-31(17-15-30)25(19-4-9-22(28)10-5-19)20-6-11-23(29)12-7-20/h4-13,25H,14-18H2,1-3H3
|
||||
| InChIKey | JQSAYKKFZOSZGJ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.9 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Hesperidin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 10621 | ||||
| Docking Score | -6.986 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C28H34O15 | ||||
| Molecular Weight | 610.6 | ||||
| Canonical SMILES |
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
|
||||
| InChI |
InChI=1S/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1
|
||||
| InChIKey | QUQPHWDTPGMPEX-QJBIFVCTSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1.1 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 15 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.